trial · primary record
Atebimetinib
Pancreatic Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 510 |
| Primary completion | 2029-02 |
| Primary endpoint | Overall Survival |
| Registry ID | NCT07562152 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:20.111Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07562152
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.